Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2020
|
Stephane Bancel Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
50,010
+0.74%
|
-
|
|
Aug 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,380,000
$69.06 P/Share
|
|
Aug 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.8%
|
$762,174
$69.32 P/Share
|
|
Aug 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.25%
|
$1,020,000
$68.45 P/Share
|
|
Aug 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Aug 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,000
-0.13%
|
$1,380,000
$69.05 P/Share
|
|
Aug 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.04%
|
$355,000
$71.5 P/Share
|
|
Aug 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.02%
|
-
|
|
Aug 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,000
-0.13%
|
$1,350,000
$75.74 P/Share
|
|
Aug 10
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,480,000
$74.27 P/Share
|
|
Aug 10
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,097
-0.09%
|
$599,178
$74.27 P/Share
|
|
Aug 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.78%
|
$817,404
$74.55 P/Share
|
|
Aug 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$750,000
$75.82 P/Share
|
|
Aug 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Aug 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$693,000
$77.49 P/Share
|
|
Aug 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,480,000
$74.89 P/Share
|
|
Aug 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 03
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.01%
|
$1,480,000
$74.89 P/Share
|
|
Aug 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.5%
|
$0
$0.99 P/Share
|
|
Aug 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,097
-0.09%
|
$599,178
$74.89 P/Share
|
|
Jul 31
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.57%
|
$839,496
$76.09 P/Share
|
|
Jul 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$770,000
$77.98 P/Share
|
|
Jul 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jul 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$738,000
$82.0 P/Share
|
|
Jul 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-52.76%
|
$1,560,000
$78.67 P/Share
|
|
Jul 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.37%
|
$773,220
$70.53 P/Share
|
|
Jul 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.05%
|
$700,000
$70.95 P/Share
|
|
Jul 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
30,000
-0.13%
|
$2,370,000
$79.03 P/Share
|
|
Jul 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$820,000
$82.22 P/Share
|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$711,000
$79.61 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-39.21%
|
$1,680,000
$84.49 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
6,326
-0.01%
|
$531,384
$84.33 P/Share
|
|
Jul 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.2%
|
$983,094
$89.45 P/Share
|
|
Jul 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$800,000
$80.39 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
SELL
Open market or private sale
|
Direct |
73,975
-100.0%
|
$6,435,825
$87.84 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
59,631
+22.36%
|
$1,013,727
$17.51 P/Share
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$783,000
$87.84 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.04%
|
$710,000
$71.07 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-33.72%
|
$1,420,000
$71.08 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,281
-0.56%
|
$1,277,703
$63.98 P/Share
|
|
Jul 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$620,000
$62.04 P/Share
|